For instance, the classic antidiabetic drug metformin, described as an adiponectin agonist, has been shown to increase serum adiponectin levels and has gained attention in oncology for its demonstrated antitumor effects, particularly in breast cancer [29]. This evidence concerns the gene ADIPOQ and breast cancer.